HARTE HANKS INC(HHS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,332 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
HHS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for HARTE HANKS INC (HHS), a Industrials sector company. 13F Pro's AI-powered ranking engine scores HHS at 31.0/100 on a 32-signal composite quality model, placing it at rank #2,332 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (14.0) and revenue scale (21.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), HARTE HANKS INC reports quarterly revenue of $37.3M, net income of $-628.0K, an operating margin of -2.1%. Top institutional holders of HHS by reported 13-F value include BLAIR WILLIAM & CO/IL, WESTERLY CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HHS trades on the Nasdaq exchange and files with the SEC under CIK 45919. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HARTE HANKS INC directly from SEC EDGAR. HARTE HANKS INC's 13F Pro composite quality score has ranged between 19 and 55 since 2022, currently 31.0 — a declining long-term trajectory across 22 quarterly and live scoring snapshots.
Revenue
Q1 2026
$37.3M
Net Income
Q1 2026
$-628.0K
Free Cash Flow
Q1 2026
$-922.0K
Operating Margin
Q1 2026
-2.1%
ROIC
Q1 2026
-3.8%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-13.9% YoYNet Income
+97.3% YoYOperating Income
-81.6% YoYEPS (Diluted)
+97.3% YoYTotal Assets
-9.8% YoYTotal Debt
Op. Cash Flow
+41.9% YoY| Metric | FY 2025 | FY 2024 | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $159.6M -13.9% | $185.2M -4.8% | $194.6M -10.6% | $217.6M -43.3% | $383.9M -5.1% | $404.4M |
| Net Income | $-811.0K +97.3% | $-30.3M -302.4% | $15.0M +157.0% | $-26.3M +37.3% | $-41.9M | — |
| Operating Income | $386.0K -81.6% | $2.1M -72.6% | $7.6M +135.4% | $-21.6M +47.1% | $-40.9M +24.1% | $-53.8M |
| EPS (Diluted) | $-0.11 +97.3% | $-4.15 -335.8% | $1.76 +141.3% | $-4.26 -530.2% | $-0.68 +68.2% | $-2.13 |
| Total Assets | $91.8M -9.8% | $101.8M -5.6% | $107.9M -2.1% | $110.2M -15.8% | $130.8M -38.7% | $213.4M |
| Total Debt | — | — | $5.0M -73.3% | $18.7M | $0.00 | $0.00 |
| Operating Cash Flow | $-1.7M +41.9% | $-3.0M -69.4% | $-1.8M -114.6% | $12.1M +139.3% | $-30.8M -311.1% | $14.6M |
AI Insight: HHS Financial Trends
Harte Hanks faces persistent revenue contraction with operating performance near breakeven despite stabilized equity.
• Revenue declined 18% from $45M in Q2 2024 to $37M in Q1 2026, with every quarter showing year-over-year deterioration.
• Operating income swung wildly between -$2M and $2M; latest quarter at -$1M signals continued structural profitability challenges.
• Operating cash flow highly volatile (ranging -$5M to +$4M) with Q1 2026 at -$1M; no sustained positive conversion.
⚠ Revenue stabilized at $40M in Q4 2025 but fell again to $37M in Q1 2026, suggesting near-term floor not yet reached.
⚠ Equity held steady around $20–22M despite cumulative operating losses; debt figures unavailable limits leverage assessment.
AI Insight: HHS Ratio Trends
Harte Hanks deteriorated sharply into Q1 2026, with negative operating margins, collapsing ROIC to -15.3%, and profitability eroding across all return metrics.
• Operating margin turned -2.1% in Q1 2026, worst since Q4 2024's -3.3%, after near-breakeven Q4 2025.
• ROIC collapsed from 10.2% in Q3 2025 to -15.3% in Q1 2026, erasing two quarters of recovery.
• Net profit margin swung from +5.5% in Q4 2025 to -1.7% in Q1 2026, reversing sole quarterly profit.
⚠ TTM results deeply negative across OpMargin (-0.2%), NPM (-0.7%), ROE (-5.2%), ROA (-1.2%), ROIC (-1.7%).
⚠ Q1 2026 marks third consecutive quarter of negative ROIC; pattern suggests structural headwinds, not seasonality.
Get alerted when HHS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HARTE HANKS INC including:
Top Institutional Holders of HHS
BLAIR WILLIAM & CO/IL
$1.5M660,845 shWESTERLY CAPITAL MANAGEMENT, LLC
$1.4M627,000 shVANGUARD CAPITAL MANAGEMENT LLC
$588.0K259,036 shKrilogy Financial LLC
$339.2K118,175 shRAFFLES ASSOCIATES LP
$199.2K87,757 shGEODE CAPITAL MANAGEMENT, LLC
$131.4K57,877 shDIMENSIONAL FUND ADVISORS LP
$96.8K42,621 shBRIDGEWAY CAPITAL MANAGEMENT, LLC
$74.0K32,600 shVANGUARD FIDUCIARY TRUST CO
$69.5K30,619 shBlackRock, Inc.
$65.5K28,861 sh
| Fund | Value | Shares |
|---|---|---|
| BLAIR WILLIAM & CO/IL | $1.5M | 660,845 |
| WESTERLY CAPITAL MANAGEMENT, LLC | $1.4M | 627,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $588.0K | 259,036 |
| Krilogy Financial LLC | $339.2K | 118,175 |
| RAFFLES ASSOCIATES LP | $199.2K | 87,757 |
| GEODE CAPITAL MANAGEMENT, LLC | $131.4K | 57,877 |
| DIMENSIONAL FUND ADVISORS LP | $96.8K | 42,621 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $74.0K | 32,600 |
| VANGUARD FIDUCIARY TRUST CO | $69.5K | 30,619 |
| BlackRock, Inc. | $65.5K | 28,861 |
More Industrials Companies
View all Industrials →Put HHS on your watchlist
Track score changes the day HARTE HANKS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HHS a good stock to buy?
13F Pro's AI-powered analysis of HARTE HANKS INC (HHS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HHS are available on the HHS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HHS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HHS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HARTE HANKS INC's investment landscape.